FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the area of chemical and pharmaceutical industry and medicine and relates to methods of production of antioxidant and membrane-protective preparations with a high content of an active substance. The method of production of a tablet of ethylmethylhydroxypyridine succinate, an antioxidant preparation forte, is characterized by a granulate being produced by granulation in a boiling (fluidised) layer from a mixture of pre-sifted substances of ethylmethylhydroxypyridine succinate, kaolin, microcrystalline cellulose and a moistening agent - 5 to 7% water solution of povidone, the granulate being powdered with a mixture of colloidal silicon dioxide, calcium stearate, talc, sodium carboxymethyl starch, subjecting the resulting mixture to dry granulation followed by pressing into tablets containing 250 to 500 mg ethylmethylhydroxypyridine succinate, coating them by spraying a suspension of a hypromellose-based film former.
EFFECT: production of antioxidant and membrane-protective preparations with a high content of an active substance.
3 cl, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING AN ANTIOXIDANT AGENT IN THE FORM OF A TABLET WITH PROLONGED EFFECT | 2019 |
|
RU2712445C1 |
METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION HAVING NEUROPROTECTIVE ACTIVITY IN CHRONIC CEREBRAL ISCHEMIA | 2023 |
|
RU2816359C1 |
PHARMACEUTICAL COMPOSITION IN THE FORM OF A COATED TABLET | 2022 |
|
RU2786073C1 |
ANXIOLYTIC, SEDATIVE AND ANTI-STRESS MEDICINAL PRODUCT AND METHOD OF ITS OBTAINING | 2023 |
|
RU2814110C1 |
PHARMACEUTICAL COMPOSITION CONTAINING ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE | 2021 |
|
RU2798106C1 |
PHARMACEUTICAL COMPOSITION WITH 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE FOR ORAL ADMINISTRATION AND METHOD FOR PREPARING IT | 2010 |
|
RU2444359C1 |
PELLETISED DRUG SHOWING ANTIVIRAL AND INTERFERONOGENIC ACTION, AND METHOD FOR PREPARING IT | 2010 |
|
RU2449792C1 |
SOLID INDIVIDUAL HIGH 2-ETHYL-6-METHYL-3-PYRIDIN-3-OLE HYDROCHLORIDE DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2448686C1 |
PHARMACEUTICAL COMPOSITION SHOWING SPASMOLYTIC ACTIVITY, METHOD OF ITS PREPARING | 2001 |
|
RU2183119C1 |
MEDICINAL AGENT POSSESSING ANTI-MIGRAINE EFFECT AND METHOD FOR ITS PREPARING | 2006 |
|
RU2313340C1 |
Authors
Dates
2021-06-16—Published
2020-06-11—Filed